Podcast Q&A: Making HEOR More Accessible to Patients
This podcast segment features the Q&A from OPEN Health's October 13, 2022 webinar and features an expert panel, including Danielle [...]
Podcast Q&A: An Introduction to Infectious Disease Modeling
This podcast segment from ICON's September 29, 2022 webinar features the Q&A with Marija Zivkovic-Gojovic, Richard Pitman, and Pragya Khurana [...]
Getting Real About Real-World Data
The terms “Real-World Data” (RWD) and “Real-World Evidence” (RWE) are often thrown around in the life science industry, [...]
Using Real-World Data for Patients with Multiple Sclerosis: A New Machine Learning Model for the Expanded Disability Status Scale (EDSS)
Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds [...]
Podcast Q&A: Evidence Generation Planning
This podcast segment from Syneos Health's July 26, 2022 webinar features the Q&A with Colin Oliver, Anila Dede, Erwin De [...]
Critical Contrast: Prelude Therapeutics (NASDAQ:PRLD) versus Vertex Pharmaceuticals (NASDAQ:VRTX)
Prelude Therapeutics ( NASDAQ:PRLD – Get Rating ) and Vertex Pharmaceuticals ( NASDAQ:VRTX – Get Rating ) are both medical [...]
Abliva AB (OTCMKTS:NEVPF) & KemPharm (NASDAQ:KMPH) Critical Contrast
Abliva AB (publ) ( OTCMKTS:NEVPF – Get Rating ) and KemPharm ( NASDAQ:KMPH – https://report.stocknews.com/sign-up/ticker/?ticker=KMPH&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=KMPH&utm_content=text_link ) are both medical companies, [...]
Contract research organization Service Market Trends, Leading Key Players, Future Growth, Revenue, Demand Forecast, Applications 2021-2027
A comprehensive overview of the contract research organization services market is recently added by UnivDatos Market Insights to its humongous [...]
Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
This podcast segment from Self Care Catalysts' June 29, 2022 webinar features the Q&A with Renee Willmon, MSc, Senior Director, [...]
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 | Business Wire
NEW YORK & BOSTON & WILMINGTON, Del.--( BUSINESS WIRE )--Pfizer Inc. (NASDAQ:PFE), MorphoSys U.S. Inc., a fully owned subsidiary of [...]
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
No treatment effect observed in this patient population; substantial improvement in 6-minute walk test seen in both placebo and active [...]
Global Lymphoma Antibodies Market & Clinical Trials Report 2022-2028 – Polivy, Adcetris, and Zynlonta have Gained Approval for the Management of Lymphoma | Nachricht
DUBLIN, June 13, 2022 /PRNewswire/ -- The "Global Lymphoma Antibodies Market & Clinical Trials Insight 2028" report has been added [...]
Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysis
Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysis e067745 - Rebecca J Williams, acting director [1] , [...]
CANbridge CAN106 Phase 1 Data Presented at the European Hematology Association 2022 Congress
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 10, 2022-- CANbridge Pharmaceuticals Inc. (HKEX:1228) , a China and US-based global biopharmaceutical company committed [...]
FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials
China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the [...]
Global Biosimilars Market Trends, Application and Regional Forecast to 2022-2028
Global Biosimilars Market Trends, Application and Regional Forecast to 2022-2028 [Bharat Book] [sonikashukla98] . Bharat Book Bureau Provides the Trending [...]
Global Biosimilars Market Analysis, Application & Forecast to 2022-2028
Bharat Book Bureau Provides the Trending Market Research Report on “Global Biosimilars Market 2022-2028” under Life Sciences Market Research Report [...]
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress – Market Newsdesk
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the [...]
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the [...]
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
The Menarini Group ("Menarini") and Radius Health, Inc. ("Radius") (NASDAQ: RDUS) (collectively, the "Companies") today announced the presentation at the [...]
Hoth Therapeutics Announces Extension of Washington University Alzheimer’s Mouse Model Study with Alzheimer’s Therapeutic HT-ALZ
The focus of the new studies is to determine a human equivalent dose of HT-ALZ for starting human clinical trials [...]
CymaBay Therapeutics Announces Presentations During The International Liver Congress 2022
NEWARK, Calif. - CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other [...]
Alnylam Reports Positive Topline Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today topline results from the Phase 2 study of cemdisiran, an investigational RNAi therapeutic [...]
Biohaven Underscores Depth of Migraine Portfolio with Data from Nurtec� ODT (rimegepant) Long-Term Open Label Study and Phase 3 Zavegepant Trial at 64th Annual Scientific Meeting of the American H… | Nachricht
31 new and encore presentations, including three late-breakers and three oral presentations, spotlight robust Nurtec ODT, zavegepant and migraine HEOR [...]
Scholar Rock Holding Corporation (SRRK) Scholar Rock to Present New Apitegromab Data Including 24-Month Efficacy and Safety Data from TOPAZ Phase 2 Trial at the 2022 Annual Cure SMA Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which [...]
